AIMCA
LGND icon

Alberta Investment Management Corp (AIMCo)’s Ligand Pharmaceuticals LGND Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,127
Closed -$476K – 1281
2022
Q4 		$476K Buy
+7,127
New +$463K ﹤0.01% 926
2019
Q3 		– Sell
-11,381
Closed -$810K – 960
2019
Q2 		$810K Sell
11,381
-23,564
-67% -$1.74M 0.01% 682
2019
Q1 		$2.74M Buy
+34,945
New +$2.65M 0.03% 419

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s LGND Position: Q1 2023 in Review

Alberta Investment Management Corp (AIMCo) sold out of Ligand Pharmaceuticals (LGND) in Q1 2023, closing a stake of 7,127 shares — an estimated $476K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in LGND in Q1 2019 and held it in 3 quarters. The position peaked at $2.74M in Q1 2019. 212 funds tracked by Wall St. Rank hold LGND as of Q1 2023.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Ligand Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 7,127 Ligand Pharmaceuticals shares in Q1 2023, an estimated $476K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Ligand Pharmaceuticals in Q1 2019 and held it in 3 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Ligand Pharmaceuticals position peaked at $2.74M in Q1 2019.
  • 212 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2023.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2023, filed 15 May 2023.